Monash Biomedicine Discovery Institute (BDI) – Cardiovascular Disease Program

    Established in 2015, the 6 Discovery Programs of the Monash BDI include: Cardiovascular Disease; Immunity and Infection; Cancer; Development and Stem Cells; Metabolic Disease and Obesity; Neuroscience. 

    The vision of the BDI is to pursue excellence in biomedical discovery science that underpins a healthy human lifespan and accelerates the ability to treat, diagnose and prevent disease.

    Research conducted within our Cardiovascular Disease Program informs on the basic principles of the cardiovascular system from cell biology through to organ systems, such as the role of brain, heart, kidney, lung and vasculature in health and disease.  Our research ultimately seeks to improve the health of our ageing population by reducing the burden of chronic cardiovascular diseases (hypertension, atherosclerosis) and the resulting major cardiovascular events (myocardial infarction, stroke).

    Major areas of current research strength and key research topics within the Monash BDI Cardiovascular Disease Program include:

    • Role of inflammation and immune cell function in cardiovascular disease
    • Novel aspects of the renin-angiotensin system in cardiovascular disease
    • Heart, kidney and lung physiology and remodelling in cardiovascular disease
    • Vascular function and extracellular matrix biology in cardiovascular disease
    • Gender and maternal health influences on cardiovascular disease